Cytological diagnosis of Adrenocortical Carcinoma with metastatic lesion in liver
Keywords:
Adrenocortical carcinoma, FNAC, Immunocytochemistry, Liver matastasis,
Abstract
Adrenocortical Carcinoma (ACC) is rare tumor with a reported incidence of 2 cases per million individuals per year. These tumors are highly aggressive and at the time of diagnosis, these are at higher stage. Here, we report a case of adrenal mass and multiple hypodense lesions in liver detected on imaging study which on subsequent USG-guided fine needle aspiration cytology (FNAC) performed from adrenal glands and liver turned out to be a ACC with metastatic lesion by using immunocytochemistry as an ancillary technique which showed tumor cells immunoreactivity for inhibin and calretinin; and negativity for cytokeratin, vimentin and epithelial membrane antigen (EMA) thus confirming the suspected morphological diagnosis and highlighting the accuracy of FNAC as a diagnostic tool.References
1. Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res ClinEndocrinolMetab2009; 23: 273–89
2. Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Cli-nEndocrinolMetab 1997; 82:2027–31
3. Wooten MD, King DK. Adrenal cortical carcinoma: Epidemiology and treatment with mitotane and a review of the litera-ture. Cancer 1993; 72:3145-55
4. Ng L, Libertino JM. Adrenocortical carcinoma: Diagnosis, evaluation and treatment. J Urol 2003; 169:5-11
5. Icard P, Chapuis Y, Andreassian B, Ber-nard A, ProyeC. Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by theFrench Association of Endocrine Surgery. Surgery 1992; 112:972-9
6. Icard P, Goudet P, Charpenay C, An-dreassian B, Carnaille B, Chapuis Y, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg. 2001; 25: 891-7
7. Centeno BA. Pathology of liver metastases. Cancer Control 2006;13:13-26
8. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Campos Carneiro P, Alves VA, et al: Adrenocortical carcinoma: Clinical and laboratory observations. Cancer 2000; 88:711-36.
9. Dang C, Mohamed H, Mandal A, Salem F. Adrenal cortical carcinoma: A case of late pulmonary metastasis. J Nat Med Assoc 2001; 93:37-9.
10. Orlando R, Pelizzo MR, Lirussi F. Adrenocortical carcinoma: A 15-year survival after complete resection and repeated resection. A retrospective study in a patient with an expected poor prognosis. Anticancer Res 2003; 23:2929-31.
2. Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Cli-nEndocrinolMetab 1997; 82:2027–31
3. Wooten MD, King DK. Adrenal cortical carcinoma: Epidemiology and treatment with mitotane and a review of the litera-ture. Cancer 1993; 72:3145-55
4. Ng L, Libertino JM. Adrenocortical carcinoma: Diagnosis, evaluation and treatment. J Urol 2003; 169:5-11
5. Icard P, Chapuis Y, Andreassian B, Ber-nard A, ProyeC. Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by theFrench Association of Endocrine Surgery. Surgery 1992; 112:972-9
6. Icard P, Goudet P, Charpenay C, An-dreassian B, Carnaille B, Chapuis Y, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg. 2001; 25: 891-7
7. Centeno BA. Pathology of liver metastases. Cancer Control 2006;13:13-26
8. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Campos Carneiro P, Alves VA, et al: Adrenocortical carcinoma: Clinical and laboratory observations. Cancer 2000; 88:711-36.
9. Dang C, Mohamed H, Mandal A, Salem F. Adrenal cortical carcinoma: A case of late pulmonary metastasis. J Nat Med Assoc 2001; 93:37-9.
10. Orlando R, Pelizzo MR, Lirussi F. Adrenocortical carcinoma: A 15-year survival after complete resection and repeated resection. A retrospective study in a patient with an expected poor prognosis. Anticancer Res 2003; 23:2929-31.
Published
2014-09-28
Section
Case Report
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
